344 related articles for article (PubMed ID: 30430356)
1. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
2. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
3. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis.
Gandelman M; Peluffo H; Beckman JS; Cassina P; Barbeito L
J Neuroinflammation; 2010 Jun; 7():33. PubMed ID: 20534165
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
[TBL] [Abstract][Full Text] [Related]
5. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
6. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
8. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis.
Estes PS; Daniel SG; McCallum AP; Boehringer AV; Sukhina AS; Zwick RA; Zarnescu DC
Dis Model Mech; 2013 May; 6(3):721-33. PubMed ID: 23471911
[TBL] [Abstract][Full Text] [Related]
9. Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice.
Bertin E; Martinez A; Fayoux A; Carvalho K; Carracedo S; Fernagut PO; Koch-Nolte F; Blum D; Bertrand SS; Boué-Grabot E
Cell Mol Life Sci; 2022 Jul; 79(8):431. PubMed ID: 35852606
[TBL] [Abstract][Full Text] [Related]
10. ALS: focus on purinergic signalling.
Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
[TBL] [Abstract][Full Text] [Related]
11. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
Volonté C; Amadio S
Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
[TBL] [Abstract][Full Text] [Related]
14. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.
Nishimoto Y; Nakagawa S; Hirose T; Okano HJ; Takao M; Shibata S; Suyama S; Kuwako K; Imai T; Murayama S; Suzuki N; Okano H
Mol Brain; 2013 Jul; 6():31. PubMed ID: 23835137
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X
Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
18. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.
McLeod VM; Chiam MDF; Lau CL; Rupasinghe TW; Boon WC; Turner BJ
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32621747
[TBL] [Abstract][Full Text] [Related]
20. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
